Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q47477264)
Watch
English
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas
clinical trail researching phase III metastatic pancreatic cancer
In more languages
edit
Statements
sponsor
Celgene
0 references
country
United States of America
0 references
located in the administrative territorial entity
University of Alabama
0 references
Mayo Clinic Scottsdale
0 references
start time
March 2009
0 references
end time
September 2012
0 references
number of participants
861
people
0 references
research intervention
gemcitabine
1 reference
Wikimedia import URL
https://www.wikidata.org/w/index.php?title=Wikidata:Property_proposal/Research_intervention&oldid=631433901
has goal
medical treatment
0 references
distribution format
randomized controlled trial
0 references
minimum age
18
years old
0 references
maximum age
79
years old
0 references
official website
https://clinicaltrials.gov/ct2/show/NCT00844649
language of work or name
English
0 references
excluding
patient
medical condition
brain metastasis
0 references
including
patient
medical condition
pancreatic adenocarcinoma
0 references
diagnosis
duration
6
week
0 references
diagnosis
determination method
computed tomography
0 references
diagnosis
determination method
magnetic resonance imaging
0 references
male
0 references
female
medical condition
human pregnancy
0 references
Identifiers
ClinicalTrials.gov ID
NCT00844649
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit